Ann: Bodyguard Results, page-111

It's interesting to note that pretty much all of the historical naysayers are negative on these results. And pretty much the majority of past upbeat holders are positive on these results. Would be interesting to hear from those who were positive before today's announcement in respect to Bodyguard but are now negative and vice-versa.

Me I've always been a bit skeptical about Bodyguard, particularly around the previous results announced on a very small sample. But today's results give me MUCH more optimism of the potential success of Bodyguard. The double-blind clinical trial compared an alpha version of Bodyguard against the world’s largest selling topical non‐ steroidal anti‐inflammatory drug product and came out WELL ON TOP.

You can bend and stretch and re-align all the wording of the announcement to suit your argument but you CANNOT deny this one fact. Bodyguard, according to the double-blind FDA-approved testing methodology is BETTER.

We know OBJs technology works. P&G wouldn't be so far in bed with them if it didn't. What is Bodyguard actually achieving? It's taken a proven naturally occurring substance Lubricen and put it in a form that makes it more effective in application to the body. The effect of Lubricen on joint pain is not in question. The trialists have spoken. The main question now is who is interested in partnering OBJ in distribution. That's the next driver as far as Bodyguard is concerned and a question that I am sure everyone is keen to have answered as soon as possible.